The
Global Peptides Market
is anticipated to rise at a significant rate in the coming years due to rising
applications and scope across the globe. Peptides are short chains of amino
acids that are connected with the help of peptide bonds. In other words, they
are the building blocks of proteins. Once peptides construct a long chain of
amino acids, they turn out to be proteins. One of the vital proteins present in
our skin is collagen. Collagen offers thickness and elasticity to our skin. A
wide range of benefits is associated with the use of these peptides. The
peptides market is currently witnessing a significant trend of the emergence of
peptide therapeutics as an enhanced potent drug. The scope of the product is
inclined to oncology and hormonal therapy applications.
The
factors that are playing a key role in raising the peptides market share may
include technological improvements, rise in the prevalence of chronic
disorders, augmented demand for effective drugs and technology, rise in the
investments by leading players on research and development activities, product
introductions, rising prevalence of metabolic disorders, rise in the number of
cancer patients, and decrease in the production cost of peptide drugs.
On
the other hand, the factors that are acting as major hurdles in the peptides
market growth may entail rise in the complexity of peptides in the production
process, soaring cost of R&D activities and lack of awareness among the
consumers regarding use of peptides. Global Peptides Market is segmented on the
basis of type as Tripeptide, Dipeptide, Tetrapeptide, Monopeptide, Hexapeptide,
Heptapeptide, Pentatetrapeptide, and others. Peptides Market is segregated by
application as Medical, Pharmaceutical, Clinical, and others.
Peptides
Market is classified by geography as North America, Southeast Asia, China,
Europe, Japan, and India. Among all the geographical regions, North America is
currently leading the peptides market and it is estimated that the market will
witness a robust growth rate in the near future, the reason being existence of
a large number of players in the particular region, rise in the awareness level
among the consumers regarding the usage of the product and robust developments
in the healthcare infrastructure.
On
the contrary, Asia Pacific and Europe are also displaying a huge growth in the
peptides market as a huge number of market opportunities are emerging in these
regions. The prominent players operating in the Peptides Market are recognized
as Eli Lilly and Co., Sanofi, Novartis AG, GlaxoSmithKline Plc, F. Hoffmann-La
Roche Ltd., Bachem Holding AG, Amgen Inc, Teva Pharmaceutical Industries Ltd.,
Takeda Pharmaceutical Co. Ltd., and Pfizer Inc.
Comments
Post a Comment